Buprenorphine products for the pharmacologic management of opioid addiction: Why shouldn't advanced practice nurses prescribe?

Journal of Addictions Nursing

Volumn 17, Issue 2, 2006, Pages 139-145

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745699288     PISSN: 10884602     EISSN: 15487148     Source Type: Journal    
DOI: 10.1080/10884600600668518     Document Type: Review

References (27)

1. American Academy of Nurse Practitioners. (2004). U.S. Nurse Practitioner Workforce 2004 Fact Sheet. Retrieved February 13, 2006, from http://www.aanp.org/NR/rdonlyres/ exenwjn13eybaktqli266uvk4kw364gapgzjhyyvey2d7fziiv2uhd55atxojxgdjrp3q5vu4e6akp/ NPStateWorkforceData1204.pdf
2. American Association of Colleges of Nursing. (January 28, 1998). AACN Position Statement: Certification and Regulation of Advanced Practice Nurses. Retrieved February 13, 2006, from http://www.aacn.nche.edu/Publications/ positions/cerreg.htm
3. American College of Nurse Practitioners, (nd). What is a Nurse Practitioner? Retrieved February 12, 2006, from http://www.nurse.org/acnp/facts/ whatis.shtml
4. American Nurses Association. (August 12, 2005). Media advisory: Advanced Practice Nurses offer cost-saving solution to Medicaid reform patient-access dilemma. Retrieved February 12, 2006, from http://www.nursingworld.org/pressrel/ 2005/ma0812.htm
5. Drug Enforcement Administration. Diversion Control Website. (nd). Frequently asked questions (FAQs). Retrieved February 12, 2006, from http://www.deadiversion.usdoj.gov/drugreg/faq.htm
6. Federation of State Medical Boards of the United States, Inc. (April 2002.) Model policy guidelines for opioid addiction treatment in the medical office. Retrieved February 12, 2006, from http://www.fsmb.org/policy.htm
7. Food and Drug Administration. (2002). Physician information: Answers to frequently asked questions, NDA 20-732, NDA 20-733. Retrieved April 22, 2004, from http://www.fda.gov/cder/foi/label/2002/20732mdinfo.pdf
8. Health Resources and Services Administration, Bureau of Primary Health Care. (December 5, 2003). Use of buprenorphine in health center substance abuse treatment programs, in Program Assistance letter, document # 2004-01. Retrieved February 12, 2006, from ftp://ftp.hrsa.gov/bphc/docs/2004pals/2004-01.PDF
9. Join Together. (October 2003). National poll of physicians on barriers to widespread buprenorphine use. Retrieved February 12, 2006, from http://www.jointogether.org/resources/report-national-poll-of.html
10. Jones, J. M. (December 5, 2005). Nurses remain atop honesty and ethics list: Hold substantial lead over other professions. Princeton, NJ: Gallup Poll News Service. Retrieved February 12, 2006, from http://poll.gallup.com/content/? ci=20254
11. Kosten, T. R., Fiellin, D. A. (January 2004). Buprenorphine for office-based practice: Consensus conference overview. American Journal on Addictions, 13(Suppl. 1), S1-S7.
12. McCance-Katz, E. (March, 2004). Buprenorphine treatment protocol. Virginia Commonwealth University Division of Addiction Psychiatry.
13. National Association of Alcohol and Drug Abuse Counselors. (October 6, 2003). NAADAC lauds buprenorphine launch: Association supports counselor involvement in new drug therapy (Press Release). Retrieved October 4, 2005, from http://naadac.org/pressroom/index.php?PressReleaseID=15
14. National Association of State Alcohol and Drug Abuse Directors. (December 2002). NASADAD policy paper: The use of medications in substance abuse treatment, Washington, DC. Retrieved February 12, 2006, from http://www.nasadad.org/resource.php?doc_id=35
15. National Panel for Psychiatric-Mental Health NP Competencies. (September 2003). Psychiatric-Mental Health NP Competencies. Washington, DC: National Organization of Nurse Practitioner Faculties.
16. Opiate Medication Initiative for Rural Oregon Residents. (November 2003). Treating opiate dependence in rural communities: A guide for developing community resources. Northwest Frontier Addiction Technology Transfer Center. Retrieved February 12, 2006, from http://www.ireta.org/opiates2005/10.pdf
17. Reckitt Benckiser Suboxone® brochure. Important information for patients: What you need to know about your treatment.
18. Substance Abuse and Mental Health Services Administration. (December 10, 2002). Fact sheet: Frequently asked questions about treatment for opioid addiction using buprenorphine. Retrieved April 22, 2004, from http://www.samhsa.gov/news/bupeFAQs.htm.
19. Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National Findings. (Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 03-3836). Rockville, MD: Author.
20. Substance Abuse and Mental Health Services Administration-Center for Substance Abuse Treatment. (January 2001). E. Strain (ed). The use of buprenorphine in the pharmacologic management of opioid dependence: A curriculum for physicians.
21. Substance Abuse and Mental Health Services Administration-Center for Substance Abuse Treatment. (2004). Treatment improvement protocol #40: Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. (DHHS Publication No. SMA 04-3939.) Retrieved February 14, 2006, from http://buprenorphine.samhsa.gov/Bup%20Guidelines.pdf
22. Substance Abuse and Mental Health Services Administration-Center for Substance Abuse Treatment buprenorphine website. (nd-a). About buprenorphine therapy. Retrieved June 2, 2004, from http://www.buprenorphine.samhsa.gov/about. html
23. Substance Abuse and Mental Health Services Administration-Center for Substance Abuse Treatment buprenorphine website. (nd-b). Legislation/ Regulations. Retrieved May 15, 2003, from http://www.samhsa.gov/centers/csat/ content/dpt/regulations.htm
24. Substance Abuse and Mental Health Services Administration-Center for Substance Abuse Treatment buprenorphine website. (nd-c). Physician waiver qualifications. Retrieved April 22, 2004, from http://buprenorphine.samhsa.gov/ waiver_qualifications.html
25. Substance Abuse and Mental Health Services Administration-Center for Substance Abuse Treatment buprenorphine physician locator website. (nd-d). Physician list search. Retrieved June 2, 2004, from http://buprenorphine.samhsa. gov/bwns_locator/dr_search.htm
26. Substance Abuse and Mental Health Services Administration-Office of Applied Studies. (January 2004). The Drug Abuse Warning Network: Narcotic analgesics. Rockville, MD: Author.
27. U.S. Department of Health and Human Services. Drug Addiction Treatment Act of 2000. Public Law No. 106-310. Title XXXV-Waiver authority for physicians who dispense or prescribe certain narcotic drugs for maintenance treatment or detoxification treatment, 2000. Retrieved February 14, 2006 from http://www.buprenorphine.samhsa.gov/fulllaw.html